We have come to an age where smart biomanufacturing is transforming the bioprocessing landscape. From continuous/intensified processing to digitalization and big data, the industry is abuzz with new technologies and novel platforms that aim to revolutionize the biomanufacturing industry. CHI’s Biomanufacturing & Digitalization stream presents strategies and opportunities for companies to enable next-generation biopharm production using intensified processes, real-time monitoring and control, digital twins and predictive modeling, as well as data-driven knowledge management tools driven by AI/ML, to deliver higher throughput, reduce cost, and produce consistently safe and high-quality products.

Conferences Include:

Keynote Presentations:

Which Program Is Not Accelerated? Increasing Efficiencies in Process Development for Speed, Quality, and Safety
Gisela M. Ferreira, PhD, Director, AstraZeneca

Digital Innovation in Transforming Molecules of Today into the Medicines of Tomorrow
Cenk Undey, PhD, Vice President & Global Head, PTD Data & Digital, Roche/Genentech

The Golden Thread: Digital Powered Seamless Therapeutic Translation and Industrialization 
Shanti Chari, AVP, Digital Technologies and Innovation, Landmark Bio

Preparing for the Smart Factories of the Future: CDER's Journey
Thomas F. O'Connor, PhD, Deputy Director, Office of Pharmaceutical Quality, CDER, FDA